THE PREVENT TRIAL
Stopping Lymphedema Starts with PREVENT - Final 3-Year Primary Endpoint Results Published

ImpediMed Announces Clinical Trial Agreement for its SOZO Platform in Patients with End Stage Renal Disease (ESRD)